Prelude Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$984K	Sell	29,085 -4,600	-14%	-$130K	0.08%	317
2025 Q4	$917K	Buy	+33,685	New	+$1.18M	0.07%	336
2024 Q4	–	Sell	-21,000	Closed	-$933K	–	1192
2024 Q3	$933K	Buy	+21,000	New	+$954K	0.07%	403
2024 Q2	–	Sell	-15,056	Closed	-$440K	–	1194
2024 Q1	$440K	Buy	+15,056	New	+$403K	0.03%	688
2020 Q4	–	Sell	-1,281	Closed	-$45K	–	1242
2020 Q3	$45K	Sell	1,281 -2,804	-69%	-$123K	0.01%	1150
2020 Q2	$218K	Buy	+4,085	New	+$189K	0.03%	715
2019 Q2	–	Sell	-140	Closed	-$9K	–	1624
2019 Q1	$9K	Buy	+140	New	+$8.15K	﹤0.01%	1455
2018 Q4	–	Sell	-6,701	Closed	-$517K	–	1745
2018 Q3	$517K	Buy	6,701 +1,400	+26%	+$113K	0.04%	519
2018 Q2	$447K	Buy	5,301 +5,152	+3,458%	+$449K	0.04%	564
2018 Q1	$12K	Buy	+149	New	+$11.5K	﹤0.01%	1322
2017 Q4	–	Sell	-4,215	Closed	-$281K	–	1331
2017 Q3	$281K	Buy	4,215 +739	+21%	+$44.4K	0.03%	537
2017 Q2	$179K	Buy	+3,476	New	+$178K	0.02%	610
2015 Q1	–	Sell	-3,013	Closed	-$338K	–	1909
2014 Q4	$338K	Buy	+3,013	New	+$269K	0.05%	449